New ribonucleotide reductase inhibitors with antineoplastic activity.
D000818:Animals; D000970:Antineoplastic Agents; D005260:Female; D006877:Hydroxamic Acids / Q000494:pharmacology*; D006918:Hydroxyurea / Q000494:pharmacology; D007939:Leukemia L1210 / Q000188:drug therapy*; D051379:Mice; D008815:Mice, Inbred Strains; D012264:Ribonucleotide Reductases / Q000037:antagonists & inhibitors*; D013329:Structure-Activity Relationship
D000970:Antineoplastic Agents; D006877:Hydroxamic Acids; D012264:Ribonucleotide Reductases; D006918:Hydroxyurea